Drug Type Polysaccharide |
Synonyms WPCP |
Target |
Action inhibitors |
Mechanism I-kappa B kinase inhibitors, NF-κB inhibitors(Nuclear factor NF-kappa-B complex inhibitors), NOX4 inhibitors(NADPH oxidase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Kidney Injury | Preclinical | China | 01 Sep 2025 |





